Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance
Open Access
- 1 September 1999
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 106 (3), 578-590
- https://doi.org/10.1046/j.1365-2141.1999.01522.x
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trialsBritish Journal of Haematology, 1997
- Absence of detectable PML-RARα fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemiaBone Marrow Transplantation, 1997
- Quantification of PML‐RARα transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT‐PCR for the detection of minimal residual disease and induction of the leukaemia‐specific mRNA by alpha interferonBritish Journal of Haematology, 1996
- SERIAL QUANTIFICATION OF MINIMAL RESIDUAL DISEASE OF t(8;21) ACUTE MYELOGENOUS LEUKAEMIA WITH RT‐COMPETITIVE PCR ASSAYBritish Journal of Haematology, 1996
- The molecular genetics of acute promyelocytic leukemiaBlood Reviews, 1993
- Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaThe Lancet, 1992
- ACUTE PROMYELOCYTIC LEUKAEMIABritish Journal of Haematology, 1992
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PMLCell, 1991
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- Association of an Inversion of Chromosome 16 with Abnormal Marrow Eosinophils in Acute Myelomonocytic LeukemiaNew England Journal of Medicine, 1983